Title : Effect of adherence measured by MEMS , ritonavir boosting and CYP 3 A 5 genotype on atazanavir pharmacokinetics in treatment - naïve HIV - infected patients
نویسندگان
چکیده
Affiliations: Univ Paris Diderot, Sorbonne Paris Cité, INSERM, UMR 738, F-75018 Paris, France; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco; APHP, HôpitalBicêtre, Clinical Pharmacy, Paris, France; Univ Paris Sud, Faculty of Pharmacy, EA4123, F-92290 ChatenayMalabry, France,Laboratoire de Virologie, AP-HP Hôpital Bichat – Claude Bernard GH HUPNVS,F-75018 Paris, France; APHP, HôpitalBicêtre, Service de Génétiquemoléculaire, Pharmacogénétique et Hormonologie, Paris, France; AARDEX Group, APHP, HôpitalBicêtre, Internal Medicine, Paris, France
منابع مشابه
Non-nucleoside-reverse-transcriptase-inhibitor-based HAART and osteoporosis in HIV-infected subjects.
1. BoffitoM,KurowskiM,KruseGet al. Atazanavir enhancessaquinavir hard-gel concentrations in a ritonavir-boosted once-daily regimen. AIDS 2004; 18: 1291–7. 2. BoffitoM,MaitlandD,SamarasingheYetal. Thepharmacokineticsof HIV protease inhibitor combinations. Curr Opin infect Dis 2005; 18: 1–7. 3. Peytavin G, Dominguez S, Lamotte C et al. Minimization of the triple reciprocal lopinavir/ritonavir/amp...
متن کاملTelaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis
INTRODUCTION We report the SVR12 final analysis of a phase 3 study of telaprevir in combination with peginterferon (P)/ribavirin (R) in HCV-genotype 1, treatment-naïve and -experienced patients with HCV/HIV co-infection (INSIGHT). MATERIALS AND METHODS Patients receiving stable, suppressive HIV antiretroviral (ARV) therapy, containing atazanavir/ritonavir, efavirenz, darunavir/ritonavir, ralt...
متن کاملCorrelations between atazanavir Ctrough and hyperbilirubinemia: a case report
INTRODUCTION Hyperbilirubinemia is a common side effect of the antiretroviral agent atazanavir but is generally reversible upon discontinuation of treatment. We used therapeutic drug monitoring to investigate the occurrence of hyperbilirubinemia in a 49-year-old Hispanic man infected with HIV, following an overdose of ritonavir in ritonavir-boosted atazanavir therapy. CASE PRESENTATION A 49-y...
متن کاملPharmacokinetics of Etravirine Combined with Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients
Objectives. TEACH (NCT00896051) was a randomized, open-label, two-arm Phase II trial to investigate the pharmacokinetic interaction between etravirine and atazanavir/ritonavir and safety and efficacy in treatment-experienced, HIV-1-infected patients. Methods. After a two-week lead-in of two nucleoside reverse transcriptase inhibitors (NRTIs) and atazanavir/ritonavir 300/100 mg, 44 patients rece...
متن کاملRole of P-glycoprotein in the distribution of the HIV protease inhibitor atazanavir in the brain and male genital tract.
The blood-testis barrier and blood-brain barrier are responsible for protecting the male genital tract and central nervous system from xenobiotic exposure. In HIV-infected patients, low concentrations of antiretroviral drugs in cerebrospinal fluid and seminal fluid have been reported. One mechanism that may contribute to reduced concentrations is the expression of ATP-binding cassette drug effl...
متن کامل